Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Monkey Pox Testing Market Revenue Growth Supported By A CAGR Of 1.88% Through 2030
The market for monkeypox testing has experienced consistent expansion, projecting a rise from $1.52 billion in 2025 to $1.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.4%. This growth trajectory during the preceding period was influenced by factors such as the worldwide dissemination during the 2022 outbreak, constraints in diagnostic capabilities, reliance on centralized laboratory facilities, insufficient availability of test kits, and delays in identifying cases.
The market for monkeypox testing is projected for consistent expansion over the approaching years, anticipated to reach a value of $1.88 billion by 2030, reflecting a compound annual growth rate of 4.3%. This projected expansion stems from several key drivers, including the scaling up of molecular testing capabilities, a greater embrace of point-of-care diagnostic solutions, amplified government efforts in disease surveillance, increased investment in research endeavors, and advancements in rapid antigen testing technologies. Furthermore, significant trends shaping the market during this forecast period involve the proliferation of sophisticated molecular diagnostic platforms, the integration of artificial intelligence for predicting outbreaks and mapping cases, the growth of internet-of-things enabled remote testing infrastructure, the creation of automated high-throughput testing systems, and a heightened incorporation of cloud-based networks for laboratory data management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp
Monkey Pox Testing Market Demand Drivers Creating New Revenue Opportunities
The escalating prevalence of monkeypox is anticipated to serve as a catalyst for the expansion of the monkeypox testing market in the foreseeable future. Monkeypox, a seldom-encountered viral illness, stems from the monkeypox virus, a classification within the orthopoxvirus genus, which shares kinship with the variola virus responsible for smallpox. Factors contributing to the surge in monkeypox occurrences include heightened person-to-person transmission, extensive international travel, and diminished population immunity resulting from the cessation of smallpox vaccination initiatives. The significance of monkeypox testing lies in its capacity to facilitate the early detection of infected individuals, thereby enabling prompt medical intervention and isolation measures crucial for curbing the disease’s propagation. Furthermore, these diagnostic tools are instrumental in monitoring epidemic trajectories and deciphering the virus’s transmission dynamics. As an illustration, World Health Organization (WHO) data from September 2023 indicates that between August 14, 2023, and September 11, 2023, there were 1,131 new confirmed mpox cases reported, accompanied by five additional fatalities linked to the disease. Consequently, the growing incidence of monkeypox is a primary driver behind the growth observed in the monkeypox testing market.
Monkey Pox Testing Market Segment Outlook: Which Categories Are Expanding The Fastest?
The monkey pox testing market covered in this report is segmented –
1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies
2) By Mode: Laboratory Testing, Point Of Care Testing
3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses
Subsegments:
1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR
2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits
3) By Other Technologies: Enzyme-Linked Immunosorbent Assay (ELISA), CRISPR-Based Testing, Serological Tests (Antibody Detection)
Monkey Pox Testing Market Trends Driving Strategic Industry Expansion
Companies prominent within the monkeypox testing sector are actively pursuing the creation of sophisticated diagnostic tools, including RT-PCR kits with lyophilized components, to bolster both the ease of access and dependability of testing. The innovation of lyophilized components entails freeze-drying essential reagents, thereby ensuring their stability under normal atmospheric conditions and eliminating the need for refrigerated transport. This advancement diminishes reliance on cold chain infrastructure, facilitates distribution to geographically isolated regions, and upholds the precision and trustworthiness of the tests. A notable instance occurred in August 2024, when Andhra Pradesh MedTech Zone (AMTZ), an Indian entity, collaborated with Transasia Diagnostics to introduce the ErbaMDx Monkeypox RT-PCR Kit. This kit, incorporating lyophilized reagents, gained approval from the Indian Council for Medical Research (ICMR) and secured emergency use authorization from the Central Drugs Standard Control Organisation (CDSCO). It boasts a substantial 12-month shelf life and demonstrates no cross-reactivity with other orthopoxviruses, ensuring highly accurate identification. Its capability for storage and transportation at room temperature renders it particularly well-suited for deployment in remote and resource-constrained environments. Ultimately, this kit contributes to reinforcing India’s readiness for epidemic response by providing accurate, dependable, and readily available monkeypox diagnostic capabilities, even in areas lacking cold chain facilities.
Monkey Pox Testing Market Key Companies And Competitive Benchmarking
Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.
Access The Complete Monkey Pox Testing Market Report:
https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report
Monkey Pox Testing Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the monkey pox testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
